Equine veterinary journal · 2026
Mass culture of equine synovial fluid-derived mesenchymal stromal cells using nonwoven polyethylene terephthalate fabrics.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yoshitomi Miho Daniel, Kuramoto Tomohide, Hatazoe Takashi, Mitsuda Kenta, Smith Henry, Misumi Kazuhiro
Аннотация
BACKGROUND: Culture protocols need to yield 100 million equine synovial fluid (SF)-derived mesenchymal stromal cells (SF-MSCs) in around 3 weeks are needed, before these cells can be evaluated as agents of articular repair in clinical trials.
OBJECTIVES: To investigate mass culture of equine SF-MSC culture protocols using nonwoven polyethylene terephthalate (PET) fabrics for the potential to meet the targets for clinical trials.
STUDY DESIGN: In vitro experiments.
METHODS: SF samples were collected from the carpal joints in thoroughbred racehorses (n = 21) undergoing arthroscopic surgery and cultured in 10% fetal bovine serum (FBS-protocol; n = 7) or 10% equine serum (ES-protocol; n = 7)-supplemented medium. Primary (P0) SF-MSCs were isolated by dish culture and then passaged on nonwoven PET fabrics in culture bottles at a seeding density of 1 × 104 cells/strip. The other 7 SF samples were cultured in ES-supplemented medium, and P0-SF-MSCs were passaged at a higher density using an automated culture device (ACD-protocol; n = 7).
RESULTS: Under the FBS and ES protocols, 0.84 ± 0.82 × 107 and 1.40 ± 0.79 × 107 P0-SF-MSCs were isolated, and 1.34 ± 0.66 × 108 and 0.94 ± 0.20 × 108 passage 1 (P1)-SF-MSCs were harvested. The respective total durations of primary and passage culture were 21.4 ± 1.8 and 27.6 ± 2.1 days duration. An ACD-protocol yielded 0.71 ± 0.32 × 107 P0-SF-MSCs, from which 0.85 ± 0.48 × 108 of P1-SF-MSCs were cultured in 20.6 ± 1.1 days.
MAIN LIMITATIONS: Visualisation of SF-MSC attached to PET nonwoven fabric, counting of SF-MSCs attached to and detached from PET nonwoven fabric, and daily quantification of SF-MSC proliferating on fabrics.
CONCLUSIONS: To support progress to clinical trials, of a sufficient number (100 million) of equine SF-MSCs need to be harvested in around 3 weeks. These goals were achieved with the FBS protocol, but further optimisation is needed for the ES protocol. Our findings on in vitro MSCs amplification suggest that SF, a potential source for non-invasively collected MSCs, is available as a promising matrix for therapeutic strategies using autologous transplantation.
OBJECTIVES: To investigate mass culture of equine SF-MSC culture protocols using nonwoven polyethylene terephthalate (PET) fabrics for the potential to meet the targets for clinical trials.
STUDY DESIGN: In vitro experiments.
METHODS: SF samples were collected from the carpal joints in thoroughbred racehorses (n = 21) undergoing arthroscopic surgery and cultured in 10% fetal bovine serum (FBS-protocol; n = 7) or 10% equine serum (ES-protocol; n = 7)-supplemented medium. Primary (P0) SF-MSCs were isolated by dish culture and then passaged on nonwoven PET fabrics in culture bottles at a seeding density of 1 × 104 cells/strip. The other 7 SF samples were cultured in ES-supplemented medium, and P0-SF-MSCs were passaged at a higher density using an automated culture device (ACD-protocol; n = 7).
RESULTS: Under the FBS and ES protocols, 0.84 ± 0.82 × 107 and 1.40 ± 0.79 × 107 P0-SF-MSCs were isolated, and 1.34 ± 0.66 × 108 and 0.94 ± 0.20 × 108 passage 1 (P1)-SF-MSCs were harvested. The respective total durations of primary and passage culture were 21.4 ± 1.8 and 27.6 ± 2.1 days duration. An ACD-protocol yielded 0.71 ± 0.32 × 107 P0-SF-MSCs, from which 0.85 ± 0.48 × 108 of P1-SF-MSCs were cultured in 20.6 ± 1.1 days.
MAIN LIMITATIONS: Visualisation of SF-MSC attached to PET nonwoven fabric, counting of SF-MSCs attached to and detached from PET nonwoven fabric, and daily quantification of SF-MSC proliferating on fabrics.
CONCLUSIONS: To support progress to clinical trials, of a sufficient number (100 million) of equine SF-MSCs need to be harvested in around 3 weeks. These goals were achieved with the FBS protocol, but further optimisation is needed for the ES protocol. Our findings on in vitro MSCs amplification suggest that SF, a potential source for non-invasively collected MSCs, is available as a promising matrix for therapeutic strategies using autologous transplantation.